Form 4: Merck Executive Johannes Oosthuizen Reports Stock Transactions
SEC Form 4 Filing
Johannes Oosthuizen, a Merck executive, reported the vesting and distribution of restricted stock units and associated tax withholding.
Summary
- On May 4, 2024, Johannes Oosthuizen, President, U.S. Market at Merck & Co., Inc., reported transactions involving Merck common stock.
- These transactions included the vesting and distribution of 912 restricted stock units, which converted into 912 shares of common stock.
- A portion of the shares (450) were withheld to cover tax obligations at a price of $127.51 per share.
- Following these transactions, Oosthuizen directly owns 23,820.949 shares of Merck common stock.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation, with no particularly positive or negative implications.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, which are closely monitored by investors.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation.
Key Dates
| Date | Description |
|---|---|
| 05/04/2022 | First vesting date of restricted stock units in three equal installments. |
| 05/04/2023 | Second vesting date of restricted stock units in three equal installments. |
| 05/04/2024 | Date of transaction: vesting of restricted stock units and tax withholding. |
| 05/06/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.